首页> 外文期刊>Oncology letters >Association between Wnt inhibitory factor 1 and receptor tyrosine kinase-like orphan receptor 2 protein expression and the clinical pathological significance in benign and malignant pancreatic lesions
【24h】

Association between Wnt inhibitory factor 1 and receptor tyrosine kinase-like orphan receptor 2 protein expression and the clinical pathological significance in benign and malignant pancreatic lesions

机译:Wnt抑制因子1和受体酪氨酸激酶样孤儿蛋白表达的关系和良性和恶性胰腺病变的临床病理意义

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Pancreatic cancer is one of the most malignant types of tumor. It is important to elucidate the underlying molecular mechanisms of pancreatic tumorigenesis and to identify novel biomarkers as therapeutic targets of pancreatic cancer. In the present study, the protein expression levels of Wnt inhibitory factor 1 (WIF1) and receptor tyrosine kinase-like orphan receptor 2 (ROR2) were examined in a collection of pancreatic ductal carcinoma and benign pancreatic lesion tissue samples using immunohistochemistry. The positive expression rate of WIF1 protein in pancreatic ductal carcinoma was demonstrated to be significantly decreased compared with that of the paracancerous tissue, benign lesions and wild-type pancreatic tissue (P=0.002, P<0.0001, P=0.001, respectively). The positive expression rate of ROR2 protein in pancreatic ductal carcinoma was demonstrated to be significantly increased compared with that of the paracancerous tissue, benign lesions and wild-type pancreatic tissue (P<0.0001). There was a negative association between WIF1 and ROR2 expression in the pancreatic ductal carcinoma samples (P=0.004). The survival period of patients with negative WIF1 and positive ROR2 protein expression was demonstrated to be significantly decreased compared with that of patients with positive WIF1 and negative ROR2 protein expression (P<0.0001). The expression levels of WIF1 and ROR2 protein reflected the incidence, development, clinical and biological behavior, and prognosis of pancreatic ductal carcinoma. Patients with negative WIF1 and positive ROR2 protein expression had poor prognosis. The results indicate that WIF1 and ROR2 are important biomarkers in pancreatic cancer.
机译:胰腺癌是最恶劣类型的肿瘤之一。重要的是要阐明胰腺炎患者的潜在分子机制,并鉴定新的生物标志物作为胰腺癌的治疗靶标。在本研究中,在使用免疫组织化学的胰腺导管癌和良性胰腺病变组织样品的收集中检查WNT抑制因子1(WIF1)和受体酪氨酸激酶样孤儿蛋白剂2(ROR2)的蛋白质表达水平。与副血管组织,良性病变和野生型胰腺组织(P = 0.002,P <0.01,P = 0.001)相比,对胰腺导管癌中的WIF1蛋白在胰腺导管癌中的阳性表达率显着降低。与副血管组织,良性病变和野生型胰腺组织(P <0.0001)相比,对胰腺导管癌中ROR2蛋白在胰腺导管癌中的阳性表达率明显增加(P <0.0001)。在胰腺导管癌样品中WIF1和ROR2表达之间存在负关联(p = 0.004)。与阳性WIF1和负ROR2蛋白表达的患者相比,对阴性WIF1和阳性ROR2蛋白表达患者的存活时间明显降低(P <0.0001)。 WIF1和ROR2蛋白的表达水平反映了胰腺导管癌的发病率,发育,临床和生物学行为和预后。阴性WiF1和阳性ROR2蛋白表达的患者预后差。结果表明,WIF1和ROR2是胰腺癌中重要的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号